Argelia Douglas
Pediatrics · Edinburg, TXNPI 1649360439
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $772 and has fallen 71.3% since, to $221 in 2025. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 64 payments — averaging $36.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$475
- Tris Pharma Inc$316
- Rhythm Pharmaceuticals, Inc.$148
- Merck$141
- Ironshore Pharmaceuticals Inc.$135
- Amgen$127
- plus $977 from 19 others
What the payments were for
- Food & beverage$2,318100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 7 | $475 |
| Tris Pharma Inc | 4 | $316 |
| Rhythm Pharmaceuticals, Inc. | 2 | $148 |
| Merck | 8 | $141 |
| Ironshore Pharmaceuticals Inc. | 4 | $135 |
| Amgen | 1 | $127 |
| AstraZeneca | 1 | $125 |
| Novo Nordisk | 1 | $122 |
| Biogen | 1 | $120 |
| GSK | 6 | $105 |
| Abbott | 3 | $85 |
| Cumberland Pharmaceuticals, Inc. | 5 | $65 |
| Genentech USA, Inc. | 4 | $52 |
| Sanofi Pasteur Inc. | 3 | $52 |
| Pfizer | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Alk-abello, Inc | 1 | $28 |
| Nestle Healthcare Nutrition Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Cipher Pharmaceuticals US LLC | 1 | $18 |
| Seqirus USA Inc | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$399
- Quillivant XR$195
- Repatha$127
- FARXIGA$125
- Sogroya$122
- SPINRAZA$120
- Jornay PM 20mg capsules (Bottle of 100)$117
How this compares
$2,318 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 12 | $81 |
| Alprazolam | 12 | $11 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Edinburg
- Diana El-ZaimEdinburg$16K
- Rodrigo ArgenalEdinburg$6K
- Pedro PiedraHouston$729K
- Jason RiehsFrisco$216K
- Ivonne Sahagun-CarreonNew Braunfels$168K
- Angela ScheuerleDallas$118K
- Dianna BurnsSan Antonio$100K
- Jason TerkKeller$93K
- Vernon SuttonHouston$90K
- Laura ScalfanoPlano$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.